Clinical Trial Update: A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rosiglitazone in combination with insulin for Type 2 diabetes mellitus has completed enrollment/status; results are not prov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED